BONEX
vs
U
USBC
BONEX
Over the past 12 months, BONEX has underperformed USBC, delivering a return of -46% compared to the USBC's +549 600% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
BONEX
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Bonesupport Holding AB
STO:BONEX
|
186.9
SEK
|
|||||
|
U
|
US BioTec Inc
OTC:USBC
|
0.5497
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
BONEX, USBC
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Bonesupport Holding AB
Revenue
|
|||||||||||
|
U
|
US BioTec Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
BONEX, USBC
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Bonesupport Holding AB
STO:BONEX
|
|||||||||
|
U
|
US BioTec Inc
OTC:USBC
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Bonesupport Holding AB | ||||
|
U
|
US BioTec Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
BONEX, USBC
Performance Gap
BONEX, USBC
Performance By Year
BONEX, USBC
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.